Earlymyocardial and skeletal muscle interstitial remodelling in systemic sclerosis: Insights from extracellular volume quantification using cardiovascular magnetic resonance

European Heart Journal Cardiovascular Imaging

Volumn 16, Issue 1, 2015, Pages 74-80

  Barison, Andrea ^a,b   Gargani, Luna ^c   De Marchi, Daniele ^a   Aquaro, Giovanni Donato ^a   Guiducci, Serena ^d   Picano, Eugenio ^c   Cerinic, Marco Matucci ^d   Pingitore, Alessandro ^c  

^a CNR   (Italy)

^b SCUOLA SUPERIORE SANT ANNA   (Italy)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^d CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Cardiac T1 mapping; Cardiovascular magnetic resonance; Late gadolinium enhancement; Myocardial fibrosis; Systemic sclerosis

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; BODY SURFACE; BONE REMODELING; CARDIAC IMAGING; CARDIAC PATIENT; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; DISEASE DURATION; EXTRACELLULAR SPACE; FEMALE; HEART FUNCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE FUNCTION; HUMAN; IMAGE ANALYSIS; MEDICAL HISTORY; MYOCARDIAL INTERSTITIAL REMODELLING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSPECTIVE STUDY; SKELETAL MUSCLE INTERSTITIAL REMODELLING; SYSTEMIC SCLEROSIS; CASE CONTROL STUDY; COHORT ANALYSIS; COMPLICATION; DIAGNOSTIC USE; ENDOMYOCARDIAL FIBROSIS; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; IMAGE QUALITY; MIDDLE AGED; MUSCULAR DISEASES; NONPARAMETRIC TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHYSIOLOGY; PROCEDURES; REFERENCE VALUE; SCLERODERMA, SYSTEMIC; SKELETAL MUSCLE; TIME;

ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; ENDOMYOCARDIAL FIBROSIS; FEMALE; FOLLOW-UP STUDIES; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DISEASES; PROSPECTIVE STUDIES; RADIOGRAPHIC IMAGE ENHANCEMENT; REFERENCE VALUES; SCLERODERMA, SYSTEMIC; STATISTICS, NONPARAMETRIC; TIME FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT; VENTRICULAR REMODELING;

EID: 84943402837     PISSN: 20472404     EISSN: 20472412     Source Type: Journal    
DOI: 10.1093/ehjci/jeu167     Document Type: Article

References (48)

1. van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall Aet al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/ European League against Rheumatism Collaborative Initiative. Arthritis Rheum 2013; 65:2737-47.
2. Barnes J, Mayes MD. Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers. Curr Opin Rheumatol 2012; 24:165-70.
3. Ferri C, Giuggioli D, Sebastiani M, Colaci M, Emdin M. Heart involvement and systemic sclerosis. Lupus 2005;14:702-7.
4. Desai CS, Lee DC, Shah SJ. Systemic sclerosis and the heart: current diagnosis and management. Curr Opin Rheumatol 2011;23:545-54.
5. Ioannidis JPA, Vlachoyiannopoulos PG, Haidich A-B, Medsger TA, Lucas M, Michet CJ et al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 2005;118:2-10.
6. Ranque B, Authier F-J, Berezne A, Guillevin L, Mouthon L. Systemic sclerosis-associated myopathy. Ann N Y Acad Sci 2007;1108:268-82.
7. Tzelepis GE, Kelekis NL, Plastiras SC, Mitseas P, Economopoulos N, Kampolis C et al. Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study. Arthritis Rheum 2007;56:3827-36.
8. Hachulla A-L, Launay D, Gaxotte V, de Groote P, Lamblin N, Devos P et al. Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients. Ann Rheum Dis 2009;68:1878-84.
9. Moon J, Coghlan JG, Pennell DJ. Systemic sclerosis involving the heart. Heart 2001; 86:308.
10. Plastiras SC, Kelekis N, Tzelepis GE. Magnetic resonance imaging for the detection of myocardial fibrosis in scleroderma. N Engl J Med 2006;354:2194-6.
11. Nassenstein K, Breuckmann F, Huger M, Ladd SC, Schlosser T, Kreuter A et al. Detection of myocardial fibrosis in systemic sclerosis by contrast-enhanced magnetic resonance imaging. Rofo 2008;180:1054-60.
12. Di Cesare E, Battisti S, Di Sibio A, Cipriani P, Giacomelli R, Liakouli V et al. Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI). Eur J Radiol 2013;82:e268-73.
13. Mavrogeni S, Bratis K, van Wijk K, Stavropoulos E, Hautemann D, Reiber JHC et al. Myocardial perfusion-fibrosis pattern in systemic sclerosis assessed by cardiac magnetic resonance. Int J Cardiol 2012;159:e56-8.
14. Ferreira VM, Piechnik SK, Dall'Armellina E, Karamitsos TD, Francis JM, NtusiNet al. T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. JACC Cardiovasc Imaging 2013; 6:1048-58.
15. Ferreira VM, Piechnik SK, Dall'Armellina E, Karamitsos TD, Francis JM, Choudhury RP et al. Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2012;14:42.
16. Bull S, White SK, Piechnik SK, Flett AS, Ferreira VM, Loudon M et al. Human noncontrast T1 values and correlation with histology in diffuse fibrosis. Heart 2013; 99:932-7.
17. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 2010;122:138-44.
18. White SK, Sado DM, Fontana M, Banypersad SM, Maestrini V, Flett AS et al. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. JACC Cardiovasc Imaging 2013;6:955-62.
19. Fontana M, White SK, Banypersad SM, Sado DM, MaestriniV, Flett AS et al. Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR. J Cardiovasc Magn Reson 2012;14:88.
20. Moon JC, MessroghliDR, Kellman P, Piechnik SK, RobsonMD, UganderMet al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson 2013;15:92.
21. Ntusi NA, Piechnik SK, Francis JM, FerreiraVM, Rai AB, MatthewsPMet al. Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis - a clinical study using myocardial T1-mapping and extracellular volume quantification. J Cardiovasc Magn Reson 2014;16:21.
22. Thuny F, Lovric D, Schnell F, Bergerot C, Ernande L, Cottin V et al. Quantification of myocardial extracellular volumefraction with cardiacMRimaging for early detection of left ventricle involvement in systemic sclerosis. Radiology 2014;271:373-80.
23. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-90.
24. Milanesi M, Barison A, Positano V, Masci PG, De Marchi D, Marinelli L et al. Modified cine inversion recovery pulse sequence for the quantification of myocardial T1 and gadolinium partition coefficient. J Magn Reson Imaging 2013;37:109-18.
25. Maceira A, Prasad S. Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2006;8:417-26.
26. Bondarenko O, Beek AM, Hofman MBM, Kühl HP, Twisk JWR, van Dockum WG et al. Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. J Cardiovasc Magn Reson 2005;7:481-5.
27. Pingitore A, Guiducci S, Conforti ML, DeMarchi D, Gargani L, Moggi-PignoneAet al. Early detection of myocardial and pulmonary oedema with MRI in an asymptomatic systemic sclerosis patient: successful recovery with pulse steroid. Rheumatology (Oxford) 2013;52:1920-1.
28. Díez J, Querejeta R, López B, González A, Larman M, Martínez Ubago JL. Losartandependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 2002;105:2512-7.
29. Fleischmajer R, Perlish JS, Duncan M. Scleroderma.Amodel for fibrosis. Arch Dermatol 1983;119:957-62.
30. Guiducci S, Fatini C, Rogai V, Cinelli M, Sticchi E, Abbate R et al. Angiotensinconverting enzyme in systemic sclerosis: from endothelial injury to a genetic polymorphism. Ann N Y Acad Sci 2006;1069:10-9.
31. Meune C, Vignaux O, Kahan A, Allanore Y. Heart involvement in systemic sclerosis: evolving concept and diagnostic methodologies. Arch Cardiovasc Dis 2010;103: 46-52.
32. Vacca A, Montisci R, Garau P, Siotto P, Piga M, CauliAet al. Prognostic impact of coronary microcirculation abnormalities in systemic sclerosis: a prospective study to evaluate the role of non-invasive tests. Arthritis Res Ther 2013;15:R8.
33. Pintér T, Faludi R, Magyari B, Vorobcsuk A, Kumánovics G, Minier Tet al. Mechanism of coronary flow reserve reduction in systemic sclerosis: insight from intracoronary pressure wire studies. Rheumatology (Oxford) 2011;50:781-8.
34. Fernandes F, Ramires FJA, Arteaga E, Ianni BM, Bonfá ESDO, Mady C. Cardiac remodeling in patients with systemic sclerosis with no signs or symptoms of heart failure: an endomyocardial biopsy study. J Card Fail 2003;9:311-7.
35. James TN. De subitaneis mortibus. VIII. Coronary arteries and conduction system in scleroderma heart disease. Circulation 1974;50:844-56.
36. Kobayashi H, Yokoe I, Hirano M, Nakamura T, Nakajima Y, Fontaine KR et al. Cardiac magnetic resonance imaging with pharmacological stress perfusion and delayed enhancement in asymptomatic patients with systemic sclerosis. J Rheumatol 2009;36: 106-12.
37. Bulkley BH, Ridolfi RL, Salyer WR, Hutchins GM. Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction. Circulation 1976;53:483-90.
38. Olsen NJ, King LE, Park JH. Muscle abnormalities in scleroderma. Rheum Dis Clin North Am 1996;22:783-96.
39. Schade L, Paiva EDS, Müller C de S. Skeletal and cardiac muscles involvement in systemic sclerosis. Rev Bras Reumatol 2011;51:309-10, 313.
40. Follansbee WP, Zerbe TR, Medsger TA. Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association.AmHeart J 1993;125:194-203.
41. Allanore Y, Meune C, Vonk MC, Airo P, Hachulla E, Caramaschi P et al. Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis. Ann Rheum Dis 2010;69:218-21.
42. Messroghli DR, Plein S, Higgins DM, Walters K, Jones TR, Ridgway JP et al. Human myocardium: single-breath-hold MR T1 mapping with high spatial resolution-reproducibility study. Radiology 2006;238:1004-12.
43. Piechnik SK, Ferreira VM, Dall'Armellina E, Cochlin LE, Greiser A, Neubauer S et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson 2010;12:69.
44. Roujol S, Weingärtner S, Foppa M, Chow K, Kawaji K, Ngo LH et al. Accuracy, precision, and reproducibility of four T1 mapping sequences: a head-to-head comparison ofMOLLI, ShMOLLI, SASHA, and SAPPHIRE. Radiology 2014; DOI: http://dx.doi.org/10.1148/radiol.14140296.
45. Nacif MS, Turkbey EB, Gai N, Nazarian S, van der Geest RJ, Noureldin RA et al. Myocardial T1 mapping with MRI: comparison of look-locker and MOLLI sequences. J Magn Reson Imaging 2011;34:1367-73.
46. Fontana M, Barison A, Botto N, Panchetti L, Ricci G, Milanesi M et al. CMR-verified interstitial myocardial fibrosis as a marker of subclinical cardiac involvement in LMNA mutation carriers. JACC Cardiovasc Imaging 2013;6:124-6.
47. Sado D, Flett A, Banypersad S, White S, Maestrini V, Quarta G et al. Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart 2012;98:1436-41.
48. Liu C-Y, Liu Y-C, WuC, Armstrong A, Volpe GJ, van der Geest RJ et al. Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2013;62:1280-7.